Learn More
Invitrogen™ SOX18 Recombinant Rabbit Monoclonal Antibody (ST43-02)

Description
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Specifications
Specifications
| Antigen | SOX18 |
| Applications | Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | ST43-02 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | TBS with 40% Glycerol, 0.05% BSA and 0.05% sodium azide; pH 7.4 |
| Gene | SOX18 |
| Gene Accession No. | P35713, P43680 |
| Gene Alias | AI385749; HLTRS; HLTS; Ra; ragged; Ragl; SOX18; Sox-18; SRY (sex determining region Y)-box 18; SRY box 18; SRY-box 18; SRY-box containing gene 18; SRY-box transcription factor 18; Sry-related HMG-box gene 18; transcription factor SOX-18 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.